- Investor's Business Daily•12 hours ago
Sanofi makes sense as an acquirer for Flexion Therapeutics, an analyst said Friday, but Flexion investors were dubious.
- Investopedia•18 hours ago
Big pharma companies eagerly await key decisions on drugs from the FDA next week.
- Zacks•20 hours ago
This week's highlights include rumors regarding Sanofi (SNY) acquiring Flexion, accelerated FDA approval for a Pfizer/Merck KGaA drug and drug pricing.
SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||44.50 - 44.81|
|52 Week Range||36.81 - 45.13|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||23.07|
|Dividend & Yield||1.58 (3.54%)|
|1y Target Est||N/A|